G Berg Selected Research

G Berg Research Topics

Disease

5	Insulin Resistance 03/2014 - 01/2001
4	Inflammation (Inflammations) 01/2019 - 12/2000
3	Obesity 01/2022 - 12/2012
3	Hemorrhage 04/2004 - 07/2000
3	Neoplasms (Cancer) 01/2002 - 01/2000
3	Infections 10/2001 - 07/2000
3	Myocardial Infarction 06/2001 - 06/2000
2	Atherosclerosis 12/2012 - 05/2001
2	Cardiovascular Diseases (Cardiovascular Disease) 12/2012 - 04/2004
2	Thyroid Diseases (Thyroid Disease) 07/2006 - 09/2001
2	Hypertension (High Blood Pressure) 12/2000 - 06/2000
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Pregnancy Complications 01/2018
1	Overweight 12/2012
1	Vascular Remodeling 12/2012
1	Rupture 12/2012
1	Non-alcoholic Fatty Liver Disease 09/2012
1	Fatty Liver 01/2010
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2007
1	Necrosis 08/2006
1	Hyperthyroidism 02/2006
1	Amenorrhea 04/2004
1	Spasm (Spasms) 02/2002
1	Thyroid Neoplasms (Thyroid Cancer) 01/2002
1	Nausea 01/2002
1	Pain (Aches) 01/2002
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2001
1	Peritonitis 10/2001
1	Anorexia 10/2001
1	Stroke (Strokes) 04/2001
1	Lipodystrophy 01/2001
1	Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia) 01/2001
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2000
1	Leiomyoma (Uterine Fibroids) 09/2000
1	Venous Thrombosis (Deep-Vein Thrombosis) 07/2000
1	Pulmonary Embolism 07/2000
1	Disseminated Intravascular Coagulation 07/2000
1	Thrombosis (Thrombus) 07/2000

Drug/Important Bio-Agent (IBA)

4	oxidized low density lipoproteinIBA 06/2007 - 01/2001
3	Lipase (Acid Lipase)FDA Link 09/2012 - 01/2001
3	Triglycerides (Triacylglycerol)IBA 01/2010 - 12/2000
3	IodineIBA 07/2006 - 09/2001
3	CholesterolIBA 04/2004 - 12/2000
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2000
2	CytokinesIBA 01/2019 - 08/2006
2	Sucrose (Saccharose)IBA 03/2014 - 01/2010
2	Matrix Metalloproteinases (MMPs)IBA 03/2014 - 12/2012
2	Lipoproteins (Lipoprotein)IBA 12/2012 - 06/2007
2	AdiponectinIBA 12/2012 - 09/2012
2	C-Reactive ProteinIBA 12/2012 - 12/2000
2	LipidsIBA 01/2010 - 01/2001
2	HDL CholesterolIBA 06/2007 - 12/2000
2	LDL CholesterolIBA 06/2007 - 04/2004
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2007 - 01/2001
1	LeptinIBA 01/2022
1	3- (2,4- dichloro- 5- methoxyphenyl)- 2- sulfanyl- 4(3H)- quinazolinoneIBA 01/2022
1	ChemokinesIBA 01/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	GelatinasesIBA 03/2014
1	Biomarkers (Surrogate Marker)IBA 12/2012
1	Insulin (Novolin)FDA Link 12/2012
1	EnzymesIBA 12/2012
1	Metalloproteases (Metalloproteinases)IBA 12/2012
1	VLDL LipoproteinsIBA 01/2010
1	Apolipoproteins B (ApoB)IBA 06/2007
1	Transforming Growth Factor beta (TGF-beta)IBA 08/2006
1	Interleukin-10 (Interleukin 10)IBA 08/2006
1	Interleukin-4 (Interleukin 4)IBA 08/2006
1	Interferon-gamma (Interferon, gamma)IBA 08/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006
1	N 30IBA 04/2004
1	HDL LipoproteinsIBA 04/2004
1	lipoprotein cholesterolIBA 04/2004
1	LDL Lipoproteins (beta Lipoproteins)IBA 04/2004
1	CalciumIBA 02/2002
1	Thyrotropin Alfa FDA LinkGeneric 01/2002
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2002
1	Ferritins (Ferritin)IBA 04/2001
1	IronIBA 04/2001
1	1-dodecylpyridoxal (PLD)IBA 01/2001
1	CarbohydratesIBA 01/2001
1	Uric Acid (Urate)IBA 12/2000
1	Adrenergic Receptors (Adrenergic Receptor)IBA 09/2000
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 09/2000
1	PapaverineIBA 09/2000
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2000
1	ColforsinIBA 09/2000
1	DNA (Deoxyribonucleic Acid)IBA 09/2000
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 09/2000
1	Cyclic AMP (AMP, Cyclic)IBA 09/2000
1	Heparin (Liquaemin)FDA LinkGeneric 07/2000

Therapy/Procedure

3	Therapeutics 01/2002 - 06/2000
1	Nutritional Support (Artificial Feeding) 10/2001
1	Peritoneal Dialysis 10/2001
1	Gastrostomy 10/2001
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 05/2001
1	Secondary Prevention 04/2001
1	Drug Therapy (Chemotherapy) 09/2000
1	Critical Care (Surgical Intensive Care) 07/2000